A new generation of vaccines and boosters against SARS-CoV-2 may take a page from the anti-influenza playbook, with shots periodically tailored to target the most commonly circulating virus
In places with low vaccination rates, Covid-19 has the chance to linger, and variants develop and travel. Without global vaccine equity, this entirely predictable pattern will repeat
The new variant is a warning: unless we take urgent action to correct global vaccine inequities, we risk the emergence of further variants, some of which may evade
The mingling of messaging destined to the local tribesmen with international diplomacy, can indeed have tricky and unpredictable consequences but nobody can venture that they have had a
An infectious disease physician explains why these options are badly needed Merck and Pfizer both have oral antiviral pills under review by the FDA. Such treatments could help
Your body produces antibodies after an infection or vaccine, but these slowly decline over time. New Johnson & Johnson data sheds light on the duration of protection and
The increasing prevalence of new coronavirus variants is raising questions about how well protected those who’ve already had their Covid-19 shots are against evolving forms of the SARS-CoV-2
Covid-19 vaccination produces a more consistent immune response than a past infection. With the delta variant, the difference in protection may be even greater